Artiva Biotherapeutics awarded COO, CLO and Compliance Officer Bush Jennifer 45,000 shares at $0 per share and 135,000 derivative securities on September 9, 2026. The transactions left her with 374,529 shares and 135,000 derivative securities, equal to about 12.0% and 100.0% of the respective resulting holdings.

Key Highlights

  • Bush Jennifer’s post-transaction holding reached 374,529 Artiva Biotherapeutics shares.
  • The share award represented about 12.0% of her resulting share holding.
  • Her 135,000 derivative securities represented about 100.0% of her resulting derivative securities holding.

Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) awarded Bush Jennifer, its COO, CLO and Compliance Officer, 45,000 shares at $0 per share. The transaction also covered 135,000 derivative securities on September 9, 2026.

Award Covers Shares and Derivative Securities

Bush Jennifer’s resulting share holding was 374,529 shares. Her resulting derivative securities holding was 135,000 securities. The award was recorded on September 9, 2026, and the share consideration was $0 per share.

Holdings Show Separate Share and Derivative Stakes

The 45,000-share transaction represented about 12.0% of Bush Jennifer’s resulting share holding. The 135,000 derivative securities represented about 100.0% of her resulting derivative securities holding. The two percentages apply to the respective holdings disclosed after the transactions.